Compugen Company Description
When a drug is a mere twinkle in a scientist's eye, Compugen is there. The Israeli drug discovery company uses its expertise in computer sciences and molecular biology to predict molecular behavior and discover potential therapies and diagnostic biomarkers. It then licenses those discoveries -- focused mainly in the areas of cancer, cardiovascular disease, and immune disorders -- to other drug firms for further development, in return for milestone payments and future royalties. Compugen has formed licensing and collaboration partnerships with numerous companies, including Biosite, Medarex, Ortho-Clinical Diagnostics, and Roche.
View the Comprehensive Company Description for Compugen
The Company Description provides a historical perspective of Compugen's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Compugen's evolution in the marketplace.
